Historical Background and Taxonomy
For a long time, rubella was considered a mild and benign childhood disease. Its viral etiology was definitively proven in 1938 by researchers J. Hiro and S. Tasaka.
A true paradigm shift regarding the danger of the infection occurred in 1942, when Australian ophthalmologist N. M. Gregg established a direct link between maternal infection during pregnancy and severe birth defects in infants. He described the classic congenital rubella triad, which includes cataracts, sensorineural hearing loss, and congenital heart defects. The pathogen itself was isolated in cell culture much later, in 1962, independently by two groups of scientists led by T. Weller and P. Parkman.
In modern taxonomy, the pathogen belongs to the family Togaviridae and forms its own genus, Rubivirus. The etymology derives from the Latin word rubrum (red), referring to the characteristic maculopapular rash and generalized cutaneous flush.
Morphology and Virion Structure
The rubella virus is spherical and relatively small, with a virion diameter ranging from 60 to 70 nm. Genetic information is encoded in a single-stranded positive-sense RNA (+ssRNA) molecule. The viral core consists of a protein capsid with icosahedral symmetry, surrounded by a lipoprotein envelope (supercapsid) featuring prominent surface spikes.
The viral structure includes three key structural proteins:
- Protein C (Capsid): forms the inner nucleocapsid.
- Glycoprotein E1: embedded in the envelope, mediates the attachment (adsorption) of the virion to the membrane of a susceptible target cell. In the envelope, it forms a stable heterodimer with another glycoprotein.
- Glycoprotein E2: also located on the surface of the lipoprotein envelope (within the spikes). It serves as the primary protective antigen containing key strain-specific and virus-neutralizing epitopes.
Antigenic Properties and Resistance
The rubella virus is antigenically stable, existing in nature as a single serotype. The internal nucleocapsid antigen (protein C) is traditionally detected using the complement fixation test (CFT). External surface glycoproteins not only mediate adsorption to human cells but also confer hemagglutinating activity: the virus can agglutinate erythrocytes of certain birds, specifically pigeons, geese, and newborn (1–3-day-old) chicks.
The pathogen has low environmental stability. The presence of a lipid envelope makes it highly vulnerable to lipid solvents (ether, organic solvents, detergents). It is rapidly destroyed by formalin, chlorine-releasing compounds, ultraviolet radiation, and direct sunlight. The virus is thermolabile: heating to 100 °C inactivates it completely within 2 minutes. However, at low temperatures (frozen state), its infectious activity can persist for several years.
Cultivation Characteristics
In vitro propagation of the virus presents certain challenges. In most cell cultures, it replicates actively without causing a cytopathic effect (CPE), which significantly complicates its isolation and visualization.
Detection relies on the interference phenomenon. In primary cell cultures, cells infected with the rubella virus become resistant to superinfection by other inducing viruses (such as ECHO-11 virus or vesicular stomatitis virus, which normally cause CPE). If the cell monolayer remains intact after adding the inducer, it confirms that the cells are already occupied by the rubella virus.
Direct cytopathic effects can be observed only in specific continuous cell lines (e.g., Vero, BHK-21) or primary human embryonic tissue cultures. In such cases, focal monolayer destruction, plaque formation under an agar overlay, and cytoplasmic eosinophilic inclusions are noted.
Chicken and duck embryos, as well as monkeys, rats, and hamsters, serve as biological models (in which the infection is asymptomatic). Ferrets are of particular importance in virology: in these animals, the virus persistently replicates in parenchymal organs and can be transmitted transplacentally, making them an ideal model for studying the pathogenesis of human congenital rubella.